StockNews.com Begins Coverage on Ampio Pharmaceuticals (NYSE:AMPE)

Analysts at StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Thursday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

AMPE stock opened at $0.00 on Thursday. The company has a market capitalization of $2,383.50, a PE ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.70.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.